News
Health on MSN4d
What Does Psoriatic Arthritis Feel Like?Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...
Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage ...
Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...
Clinical Trials Arena on MSN3d
J&J’s psoriatic arthritis therapy trial meets endpointsJohnson & Johnson has reported positive results from a Phase IIIb trial of Tremfya (guselkumab) for active psoriatic ...
Johnson & Johnson (NYSE:JNJ) on Friday announced topline results from Phase 3b APEX study of Tremfya (guselkumab) in patients ...
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the ...
Johnson & Johnson announces positive results from phase 3b APEX study of Tremfya to treat adults living with active psoriatic arthritis: Spring House, Pennsylvania Monday, April 7 ...
Johnson & Johnson (JNJ) reports a Phase 3 success for its anti-inflammatory drug Tremfya in treating psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback